Combined chemo-immuno-photothermal therapy based on ursolic acid/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer
Fan Xu, Minghua Li, Zujun Que, Mingliang Su, YAO Wang, Yu Zhang, Bin Luo, Yan Li, Zhanxia Zhang, Jianhui Tian
Abstract
Combined chemo-immuno-photothermal therapy based on ursolic acid/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine is a promising strategy for the treatment of non-small cell lung cancer (NSCLC) metastasis.
Topics & Concepts
Photothermal therapyUrsolic acidNanomedicineHyaluronic acidMetastasisCancer researchPharmacologyCancerMaterials scienceChemistryMedicineNanotechnologyInternal medicineNanoparticleChromatographyAnatomyImmunotherapy and Immune ResponsesChemokine receptors and signalingCurcumin's Biomedical Applications